
Browsing restrictions can be lifted for a fee.
Solar Applied Materials Technology Corporation manufactures, recycles, refines, and sells precious chemicals/materials, special chemicals, and resources and targets/materials worldwide. The company offers a range of materials and integrated services for application in optoelectronics, information, petrochemicals, and consumer electronics industries. It provides various precious metal chemicals, including gold potassium cyanide, super gold potassium cyanide, silver potassium cyanide, silver cyanide, silver nitrate, and silver plate; precious metal materials consisting of gold and silver slug, and silver ingots, as well as tube, wire, and piece materials; and rare metal materials, such as tantalum and niobium. The company also offers sputtering targets for thin film for use in data storage media, photovoltaic and energy related, semiconductor and electronics, functional material, and bonding and vacuum component applications; and specialty chemicals for automobiles comprising antifreeze/engine coolant, brake fluid, engine cleaner, anti-friction engine treatment, power steering repair treatment, and ATF treatment products. In addition, it provides resource recycling services, such as catalyst and metals recycling and refining services; and chemical and physical inspection and analysis services. The company was formerly known as Solar Chemical Co., Ltd and changed its name to Solar Applied Materials Technology Corporation in October 1999. Solar Applied Materials Technology Corporation was incorporated in 1978 and is headquartered in Tainan, Taiwan.
1785
光洋科
-2.62%
(-0.03)
The most recent financial report for 光洋科 (1785) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1785's short-term business performance and financial health. For the latest updates on 1785's earnings releases, visit this page regularly.
According to historical valuation range analysis, 光洋科 (1785)'s current price-to-earnings (P/E) ratio is 12.7, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 光洋科 (1785) reported an Operating Profit of 958.74M with an Operating Margin of 9.19% this period, representing a growth of 44.12% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 光洋科 (1785) announced revenue of 10.43B, with a Year-Over-Year growth rate of 36.92%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 光洋科 (1785) held Total Cash and Cash Equivalents of 2.97B, accounting for 0.09 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 光洋科 (1785) achieved the “three margins increasing” benchmark, with a gross margin of 14.09%%, operating margin of 9.19%%, and net margin of 6.64%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1785's profit trajectory and future growth potential.
According to the past four quarterly reports, 光洋科 (1785)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 1.17. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
光洋科 (1785)'s Free Cash Flow (FCF) for the period is -1.55B, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 389.96% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.